No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Boronic Acids / adverse effects
-
Boronic Acids / therapeutic use
-
Bortezomib
-
Drug Monitoring
-
Humans
-
Lenalidomide
-
Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
-
Leukemia, Lymphocytic, Chronic, B-Cell / etiology
-
Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
-
Multiple Myeloma / diagnosis
-
Multiple Myeloma / etiology
-
Multiple Myeloma / therapy*
-
Myelodysplastic Syndromes / diagnosis
-
Myelodysplastic Syndromes / etiology
-
Myelodysplastic Syndromes / therapy*
-
Nurse's Role
-
Oncology Nursing
-
Prognosis
-
Pyrazines / adverse effects
-
Pyrazines / therapeutic use
-
Risk Assessment
-
Thalidomide / adverse effects
-
Thalidomide / analogs & derivatives
-
Thalidomide / therapeutic use
Substances
-
Antineoplastic Agents
-
Boronic Acids
-
Pyrazines
-
Thalidomide
-
Bortezomib
-
Lenalidomide